1. Pink Sheet

Aimmed’s Insomnia App Approved As Korea’s First Digital Therapeutic

But Reimbursement Decision May Take Time

 
• By Jung Won Shin

More approvals of digital therapeutics are expected to come in the wake of South Korea's first approval of this type of product, Aimmed’s insomnia mobile app Somzz. But reimbursement decisions on such therapies could take months and will be closely monitored going forward.

insomnia
Somzz Becomes First Approved Digital Therapeutic In Korea • Source: Shutterstock

South Korea’s Ministry of Food and Drug Safety (MFDS) has approved Aimmed Co. Ltd.’s cognitive treatment software Somzz as the country’s first digital therapeutic, paving the way for use of such products in the treatment of various diseases and disorders.

However, it could take some time for commercialization as the country still has to draw up a roadmap for the reimbursement of such

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Asia